Showing results (71-80 of 396) with videos related to

Sort By:
Pageof 40
Journal of the American Academy of Dermatology|July 22, 2017
PDL1 expression in desmoplastic melanoma is associated with tumor aggressiveness and progressionStefan Kraft, Maria-Teresa Fernandez-Figueras, Nina A Richarz, et al.
Oncotarget|October 27, 2015
Overexpression of Mcl-1 confers resistance to BRAFV600E inhibitors alone and in combination with MEK1/2 inhibitors in melanomaNeel M Fofaria, Dennie T Frederick, Ryan J Sullivan, et al.
Neurosurgical Focus|March 3, 2015
Ipilimumab and craniotomy in patients with melanoma and brain metastases: a case seriesPamela S Jones, Daniel P Cahill, Priscilla K Brastianos, et al.
Nature Reviews. Drug Discovery|February 2, 2011
TesamorelinCarl Grunfeld, Argyris Dritselis, Peter Kirkpatrick
Nature Reviews. Drug Discovery|March 2, 2012
TafamidisGerard Said, Seden Grippon, Peter Kirkpatrick
Neurosurgical Focus|July 7, 2007
Surgery for brain edemaPeter Hutchinson, Ivan Timofeev, Peter Kirkpatrick
The Lancet. Oncology|February 23, 2010
Vascular endothelial growth factor targeted therapy in the perioperative setting: implications for patient careDebashish Bose, Funda Meric-Bernstam, Wayne Hofstetter, et al.
Journal of the National Cancer Institute|February 11, 2014
Genetic alterations and personalized medicine in melanoma: progress and future prospectsKlaus G Griewank, Richard A Scolyer, John F Thompson, et al.
Cancer Chemotherapy and Pharmacology|May 8, 2004
A phase I, dose escalation trial of ZD0473, a novel platinum analogue, in combination with gemcitabineKeith T Flaherty, James P Stevenson, Maryann Redlinger, et al.
Pageof 40